Malignant Rhabdoid Tumors (MRT)
Oncology·MeSH: Sarcoma, Synovial
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Malignant Rhabdoid Tumors (MRT)?
There are 1 clinical trial targeting Malignant Rhabdoid Tumors (MRT) tracked by BioSniper.
What is the prevalence of Malignant Rhabdoid Tumors (MRT)?
The estimated prevalence of Malignant Rhabdoid Tumors (MRT) is approximately 0.1 per 100,000 population.
Deep-dive into Malignant Rhabdoid Tumors (MRT)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis